Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
4.850
-0.060 (-1.22%)
May 20, 2026, 1:10 PM CST
SHE:000597 Revenue
Northeast Pharmaceutical Group had revenue of 2.01B CNY in the quarter ending March 31, 2026, with 3.03% growth. This brings the company's revenue in the last twelve months to 7.13B, down -5.00% year-over-year. In the year 2025, Northeast Pharmaceutical Group had annual revenue of 7.07B, down -5.70%.
Revenue (ttm)
7.13B
Revenue Growth
-5.00%
P/S Ratio
0.98
Revenue / Employee
1.25M
Employees
5,727
Market Cap
7.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.07B | -427.70M | -5.70% |
| Dec 31, 2024 | 7.50B | -740.62M | -8.98% |
| Dec 31, 2023 | 8.24B | -565.77M | -6.42% |
| Jan 1, 2023 | 8.81B | 663.83M | 8.15% |
| Dec 31, 2021 | 8.15B | 760.76M | 10.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KPC Pharmaceuticals,Inc. | 5.80B |
| Cisen Pharmaceutical | 3.37B |
| Zhejiang Tianyu Pharmaceutical | 3.11B |
| Guizhou Bailing Group Pharmaceutical | 2.93B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.12B |
| Shandong Wit Dyne Health | 2.02B |
| Guangxi Wuzhou Zhongheng Group | 1.58B |
| Zhejiang Garden Biopharmaceutical | 1.19B |